Fig. 3
From: Increased autoantibodies against incretin indicate poor prognosis in patients with diabetes
Age-adjusted survival curves according to incretin antibody status. (a) Kaplan–Meier analysis demonstrated significantly poorer survival in the GIP antibody-positive group than in the antibody-negative group (P = 0.0057). (b) Similarly, the GLP-1 antibody-positive group exhibited worse survival than the antibody-negative group (P = 0.0487). (c) Baseline characteristics of the age-adjusted sample, including the number of subjects, sex distribution, and mean age (± SD) in each antibody-positive and -negative group. GIP glucose-dependent insulinotropic peptide, GLP-1 glucagon-like peptide-1, SD standard deviation.
